1. The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy
   Santiago Rello-Varona et al, 2015, Front. Oncol. CrossRef
2. Spatial control of adult stem cell fate using nanotopographic cues
   Eun Hyun Ahn et al, 2014, Biomaterials CrossRef
3. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
   Shinji Kohsaka et al, 2014, Nat Genet CrossRef
4. null
   Brendan C. Dickson et al, 2014 CrossRef
5. RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy
   Venkatesh Rengaswamy et al, 2016, Journal of Controlled Release CrossRef
6. MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas
   Edoardo Missiaglia et al, 2017, Cancer Letters CrossRef
7. A modified human Myogenin promoter that is highly active in alveolar rhabdomyosarcoma
   Johanna Pruller et al, 2020, Cancer Gene Ther CrossRef
8. null
   Marielle Yohe et al, 2021 CrossRef
9. Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma
   Alexandra Lacey et al, 2018, Mol Cancer Ther CrossRef
10. Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma
    Erik Hedrick et al, 2019, Mol Cancer Res CrossRef
11. PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1
    Alexandra Lacey et al, 2017, Cancer Res CrossRef
12. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors
    Ravi Kasiappan et al, 2019, Mol Cancer Res CrossRef
13. Heme Oxygenase-1 Controls an HDAC4-miR-206 Pathway of Oxidative Stress in Rhabdomyosarcoma.
    Maciej Ciesla et al, 0 CrossRef
14. Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models
    A. Kahsay et al, 2022, Sci Rep CrossRef
15. Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma
    Silvia Pomella et al, 2023, Cancers CrossRef
16. Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
    Eleanor O’Brien et al, 2023, Clin Epigenet CrossRef
17. Simulated microgravity attenuates myogenesis and contractile function of 3D engineered skeletal muscle tissues
    Zhanping Ren et al, 2024, npj Microgravity CrossRef
18. Garcinol, a natural benzophenone overcomes radio and chemoresistance by targeting PI3K-PKB/AKT pathway in rhabdomyosarcoma cells
    Shobith Rangappa, 2024, Journal of Biomolecular Structure and Dynamics CrossRef